ZENI: Q3 2025 revenue up 10% year-over-year, with positive profit and new growth financing secured

About this update from Zenicor Medical Systems Ab

Revenue grew 10% year-over-year in Q3 2025, with positive operating profit and strong customer demand. A rights issue was approved to fund growth and repay loans, while strategic partnerships and clinical studies support long-term expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Zenicor Medical Systems Ab